Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nancy Ann Rigotti, M.D.

Co-Author

This page shows the publications co-authored by Nancy Rigotti and A. Evins.
Connection Strength

1.168
  1. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. J Clin Psychopharmacol. 2005 Jun; 25(3):218-25.
    View in: PubMed
    Score: 0.318
  2. Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial. J Dual Diagn. 2012; 8(2):117-125.
    View in: PubMed
    Score: 0.129
  3. A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females. J Clin Psychopharmacol. 2011 Oct; 31(5):597-602.
    View in: PubMed
    Score: 0.123
  4. Predictors of early abstinence in smokers with schizophrenia. J Clin Psychiatry. 2008 Nov; 69(11):1743-50.
    View in: PubMed
    Score: 0.101
  5. Smoking cessation in patients with psychiatric disorders. Prim Care Companion J Clin Psychiatry. 2008; 10(1):52-8.
    View in: PubMed
    Score: 0.095
  6. Smoking cessation in patients with psychiatric disorders. J Clin Psychiatry. 2007 Sep; 68(9):1404-10.
    View in: PubMed
    Score: 0.093
  7. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. J Clin Psychopharmacol. 2007 Aug; 27(4):380-6.
    View in: PubMed
    Score: 0.092
  8. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. J Clin Psychiatry. 2005 Sep; 66(9):1184-90.
    View in: PubMed
    Score: 0.081
  9. Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction. J Clin Psychiatry. 2004 Mar; 65(3):307-11; quiz 452-3.
    View in: PubMed
    Score: 0.073
  10. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob Res. 2001 Nov; 3(4):397-403.
    View in: PubMed
    Score: 0.062
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.